|
57
|
258
|
3shaH |
Human thrombin in complex with ubthr97 |
|
3
|
31
|
3s7kA |
Structure of thrombin mutant y225p in the e form |
|
56
|
258
|
3s7kB |
Structure of thrombin mutant y225p in the e form |
|
5
|
29
|
6eo6L |
X-ray structure of the complex between human alpha-thrombin and modified 15-mer dna aptamer containing 5-(3-(2-(1h-indol-3-yl)acetamide-n-yl)-1-propen-1-yl)-2'-deoxyuridine residue |
|
6
|
30
|
6eo7L |
X-ray structure of the complex between human alpha-thrombin and modified 15-mer dna aptamer containing 5-(3-(acetamide-n-yl)-1-propen-1-yl)-2'-deoxyuridine residue |
|
3
|
28
|
3rm0L |
Human thrombin in complex with mi354 |
|
58
|
258
|
3rlwH |
Human thrombin in complex with mi328 |
|
58
|
258
|
3rmoH |
Human thrombin in complex with mi004 |
|
59
|
258
|
3rm2H |
Human thrombin in complex with mi003 |
|
57
|
258
|
3rmmH |
Human thrombin in complex with mi332 |
|
3
|
28
|
3rm2L |
Human thrombin in complex with mi003 |
|
3
|
28
|
3rmlL |
Human thrombin in complex with mi331 |
|
60
|
258
|
3rm0H |
Human thrombin in complex with mi354 |
|
59
|
258
|
3rmnH |
Human thrombin in complex with mi341 |
|
3
|
28
|
3rmnL |
Human thrombin in complex with mi341 |
|
3
|
28
|
3rmmL |
Human thrombin in complex with mi332 |
|
59
|
258
|
3rlyH |
Human thrombin in complex with mi329 |
|
3
|
28
|
3rlwL |
Human thrombin in complex with mi328 |
|
3
|
28
|
3rmoL |
Human thrombin in complex with mi004 |
|
2
|
28
|
3rlyL |
Human thrombin in complex with mi329 |
|
58
|
258
|
3rmlH |
Human thrombin in complex with mi331 |
|
2
|
34
|
4lz4A |
X-ray structure of the complex between human thrombin and the tba deletion mutant lacking thymine 3 nucleobase |
|
91
|
406
|
5to3B |
Crystal structure of thrombin mutant w215a/e217a fused to egf456 of thrombomodulin via a 31-residue linker and bound to ppack |
|
6
|
44
|
5to3A |
Crystal structure of thrombin mutant w215a/e217a fused to egf456 of thrombomodulin via a 31-residue linker and bound to ppack |
|
70
|
258
|
5nhuA |
Human alpha thrombin complexed with anopheles gambiae ce5 anticoagulant |
|
55
|
257
|
5lceH |
Thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n-(5-chloro-2-(hydroxymethyl)benzy l)pyrrolidine-2-carboxamide |
|
1
|
28
|
5lceL |
Thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n-(5-chloro-2-(hydroxymethyl)benzy l)pyrrolidine-2-carboxamide |
|
1
|
31
|
5jfdL |
Thrombin in complex with (s)-n-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-d-arginyl)pyrrolidine-2-carboxamide |
|
57
|
258
|
5gimB |
Crystal structure of thrombin-avathrin complex |
|
57
|
259
|
5gdsH |
Hirunorms are true hirudin mimetics. the crystal structure of human alpha-thrombin:hirunorm v complex |
|
3
|
30
|
5gimA |
Crystal structure of thrombin-avathrin complex |
|
3
|
36
|
5gdsL |
Hirunorms are true hirudin mimetics. the crystal structure of human alpha-thrombin:hirunorm v complex |
|
67
|
259
|
5e8eH |
Crystal structure of thrombin bound to an exosite 1-specific iga fab |
|
147
|
568
|
5edmA |
Crystal structure of prothrombin deletion mutant residues 154-167 ( form i ) |
|
7
|
33
|
5e8eL |
Crystal structure of thrombin bound to an exosite 1-specific iga fab |
|
107
|
550
|
5edkA |
Crystal structure of prothrombin deletion mutant residues 146-167 ( form ii ). |
|
56
|
258
|
5ahgH |
Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine |
|
1
|
28
|
5ahgL |
Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine |
|
66
|
259
|
4yesB |
Thrombin in complex with (s)-(4-chloro-2-((1-(5-methyl-1h-pyrrole-2-carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium |
|
59
|
257
|
5afyH |
Thrombin in complex with 3-chloro-benzamide |
|
5
|
29
|
4yesA |
Thrombin in complex with (s)-(4-chloro-2-((1-(5-methyl-1h-pyrrole-2-carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium |
|
1
|
28
|
5afzL |
Thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl-propanamide |
|
59
|
257
|
5afzH |
Thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl-propanamide |
|
57
|
258
|
4ufgH |
Thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-((1s)-2-((4- carbamimidoylphenyl)methylamino)-1-methyl-2-oxo-ethyl)-n-methyl-3- phenyl-propanamide ethane |
|
3
|
32
|
4rkjA |
Crystal structure of thrombin mutant s195t (free form) |
|
58
|
258
|
4ufeH |
Thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl-propanamide |
|
1
|
28
|
4uehL |
Thrombin in complex with benzamidine |
|
3
|
36
|
4thnL |
The crystal structure of alpha-thrombin-hirunorm iv complex reveals a novel specificity site recognition mode. |
|
58
|
258
|
4ufdH |
Thrombin in complex with 4-(((1-((2s)-1-((2r)-2-(benzylsulfonylamino)- 3-phenyl-propanoyl)pyrrolidin-2-yl)-1-oxo-ethyl)amino)methyl) benzamidine |
|
1
|
28
|
4udwL |
Thrombin in complex with 1-(2r)-2-amino-3-phenyl-propanoyl-n-(2, 5dichlorophenyl)methylpyrrolidine-2-carboxamide |
